Comments
Loading...
Lexicon Pharmaceuticals Rapporto sugli interessi allo scoperto
LXRXNASDAQ
Report sulle vendite allo scoperto
Il short interest su Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 28.84M a 28.38M. Questo rappresenta il 21.81% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Lexicon Pharmaceuticals Corp (XNAS:LXRX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.81M azioni scambiate al giorno, ci vorrebbero 15.72 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
28.38M
Vendite allo scoperto %
21.8%
Giorni di copertura
15.72
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 21.81% | 130,147,157 | 28,381,788 | 1,805,308 | 15.72 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 22.16% | 130,147,157 | 28,842,583 | 1,479,599 | 19.49 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | 21.44% | 130,147,157 | 27,905,830 | 2,923,083 | 9.55 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 20.79% | 130,147,157 | 27,056,081 | 3,268,157 | 8.28 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 22.49% | 129,926,297 | 29,213,960 | 3,680,439 | 7.94 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 25.56% | 129,926,297 | 33,206,588 | 6,567,909 | 5.06 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 28.91% | 129,926,297 | 37,564,916 | 3,781,344 | 9.93 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 29.88% | 129,926,297 | 38,825,388 | 3,814,605 | 10.18 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 33.12% | 129,926,297 | 43,028,675 | 4,192,859 | 10.26 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 28.69% | 129,926,297 | 37,271,773 | 7,002,737 | 5.32 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 31.81% | 129,926,297 | 41,331,814 | 11,854,154 | 3.49 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 26.92% | 162,980,867 | 43,881,199 | 47,251,386 | 1 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 24.09% | 162,980,867 | 39,259,612 | 15,148,389 | 2.59 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 29.12% | 162,980,867 | 47,457,048 | 4,096,942 | 11.58 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 27.45% | 162,980,867 | 44,735,672 | 2,915,719 | 15.34 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 26.40% | 162,980,867 | 43,025,344 | 5,828,178 | 7.38 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 23.99% | 162,980,867 | 39,104,772 | 5,613,432 | 6.97 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 20.55% | 162,980,867 | 33,499,569 | 4,916,798 | 6.81 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 19.19% | 162,980,867 | 31,277,836 | 5,479,031 | 5.71 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 19.35% | 162,980,867 | 31,530,008 | 3,779,385 | 8.34 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 19.25% | 162,980,867 | 31,378,261 | 5,223,895 | 6.01 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 17.58% | 162,980,867 | 28,649,978 | 3,359,096 | 8.53 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 16.97% | 162,980,867 | 27,650,080 | 2,104,163 | 13.14 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 16.55% | 162,980,867 | 26,971,057 | 2,692,700 | 10.02 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 16.34% | 162,980,867 | 26,627,093 | 1,758,972 | 15.14 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 15.58% | 162,980,867 | 25,393,364 | 2,940,274 | 8.64 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 13.71% | 162,980,867 | 22,350,800 | 3,547,321 | 6.3 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 12.81% | 162,980,867 | 20,875,691 | 2,444,393 | 8.54 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 12.39% | 162,980,867 | 20,197,013 | 3,093,961 | 6.53 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 13.23% | 162,980,867 | 21,566,751 | 2,311,738 | 9.33 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 15.43% | 162,980,867 | 25,140,140 | 2,177,527 | 11.55 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 14.28% | 162,980,867 | 23,271,956 | 2,902,425 | 8.02 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 49.10% | 47,725,325 | 23,435,062 | 3,099,582 | 7.56 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 42.17% | 47,725,325 | 20,123,733 | 2,204,044 | 9.13 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 45.92% | 47,725,325 | 21,913,448 | 3,719,121 | 5.89 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 44.73% | 47,725,325 | 21,345,582 | 6,177,531 | 3.46 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 14.13% | 149,120,453 | 21,065,496 | 5,936,558 | 3.55 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 15.94% | 146,908,395 | 23,411,469 | 5,768,790 | 4.06 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 15.68% | 146,908,395 | 23,032,960 | 4,213,631 | 5.47 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 17.20% | 146,908,395 | 25,270,438 | 2,745,605 | 9.2 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 15.80% | 146,908,395 | 23,217,320 | 2,335,614 | 9.94 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 15.75% | 147,808,395 | 23,284,095 | 2,128,582 | 10.94 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 15.83% | 147,808,395 | 23,401,890 | 1,687,274 | 13.87 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 15.13% | 147,808,395 | 22,365,868 | 2,946,048 | 7.59 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 14.87% | 147,808,395 | 21,979,508 | 2,737,216 | 8.03 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 13.19% | 147,808,395 | 19,495,758 | 3,665,258 | 5.32 | |
LXRX | Lexicon Pharmaceuticals, Inc. | 09/29/2023 | 10/10/2023 | 13.69% | 147,808,395 | 20,239,004 | 1,725,128 | 11.73 |
In cerca di azioni più vendute allo scoperto?